Inhaler is the first generic approval of its kind.
Treatment is first non-statin LDL-C lowering treatment approved in years.
Treatments include meds for arthritis pain and allergy eye drops.
FDA cleared the first generic sodium iodide product to treat hyperthyroidism and carcinoma of the thyroid.
FDA's Center for Drug Evaluation and Research approved fewer new treatments in 2019.
Global market for peanut allergy treatments estimate at $4.5 billion.
Traditional party drug known as ecstasy is undergoing clinical trials to assist in PTSD treatment.
Novel cancer drug snags FDA approval.
Ozempic’s approval follows Jardiance’s expanded heart indication last July.
Already approved for adult patients, Fiasp is now available for children.